ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GSK Gsk Plc

1,640.50
4.50 (0.28%)
25 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  4.50 0.28% 1,640.50 1,640.00 1,640.50 1,656.00 1,635.00 1,642.00 5,918,777 16:29:57
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.71 67.54B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,636p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £67.54 billion. Gsk has a price to earnings ratio (PE ratio) of 13.71.

Gsk Share Discussion Threads

Showing 15676 to 15698 of 33100 messages
Chat Pages: Latest  628  627  626  625  624  623  622  621  620  619  618  617  Older
DateSubjectAuthorDiscuss
17/11/2017
18:00
Stop talking dividends.... this company just launched 2 blockbusters!
tradermichael
17/11/2017
17:10
Growing UK political risks hanging heavy over utilities.
essentialinvestor
17/11/2017
17:09
Annoying really as it always can get cheaper...
mj19
17/11/2017
17:01
Mj forgive me for one post on Ng on this thread but surely that fall is way overdone.

a uk interest rates are unlikely to rise dramatically in the near term

B the dividend is solid

C political risk seems to be discounted

atlantic57
17/11/2017
16:44
It's pay up time for years of overly generous dividends,
the price for those is now reflected in the share price.

essentialinvestor
17/11/2017
16:40
i know that feeling, bought national grid it tanked, bought centrica it tanked... so nothing is safe... at the moment I only hold GSK and Barc and neither is doing anything special
mj19
17/11/2017
16:33
Mj that is very helpful thanks .
I am struggling to think of Uk Companies that I would invest in just at the moment

atlantic57
17/11/2017
16:23
The problem is the debt hence no bidder GlaxoSmithKline currently boasts $5.3 billion in cash in the bank -- but it also carries $24.4 billion in debt. Had Glaxo held onto its cash, it would be rich

A consequence of Glaxo's weak profits is that the company's payout ratio (the percentage of Glaxo's profits that are paid out to shareholders in the form of dividends) now exceeds 200%. Put another way, for every $1 Glaxo earns in profits, the company pays its shareholders $2 in dividends -- $1 that it has, and $1 that it has to borrow. This is not a sustainable dividend policy, hence the drama but they are paying it through 2018... after that who knows..

mj19
17/11/2017
16:09
Surely at this valuation the company would be a very tempting bid target or am I being to simplistic
atlantic57
17/11/2017
15:39
Onward and downward. Next possible support 12718 unless it want to go the 'whole hog' at 12279.

GSK DAILY

bracke
17/11/2017
15:12
12.50 anyone?
bennodean
17/11/2017
14:53
Even I am getting tempted now .
redips2
17/11/2017
14:48
Here we go, will it hold..
essentialinvestor
17/11/2017
10:15
Technically very oversold
juju44
17/11/2017
09:57
We avoided a test of £13 yesterday because of US market strength imv.
essentialinvestor
17/11/2017
09:01
just bought some here . Fall looks overdone
juju44
17/11/2017
08:59
MJ19...bit premature?
bili1946
16/11/2017
20:27
At last we rise yeahhhhh
mj19
16/11/2017
13:42
Trelegy/closed triple, looks a great product, it's a case of whether
insurers/health services will pay the price difference to simplify
a medication regime. From memory trials appear to show some incremental
benefit in reducing exacerbations.

essentialinvestor
16/11/2017
13:36
It's giving the impression of being dragged towards £13
like some whirlpool effect, hopefully not.

essentialinvestor
16/11/2017
13:21
Nope, there's clearly an agenda here. Still, can buy nice'n'cheap while it lasts.
woodhawk
16/11/2017
13:17
is there no piece of good news that can make this rise.
spoole5
16/11/2017
10:32
16th nov TraderMichael buy tp 1950p unchanged
tradermichael
Chat Pages: Latest  628  627  626  625  624  623  622  621  620  619  618  617  Older

Your Recent History

Delayed Upgrade Clock